Key result
Prasugrel provides alternative platelet inhibition for acute stent thrombosis in a clopidogrel-resistant patient.
Population
1 patient with clopidogrel resistance due to genetic polymorphism resulting in acute stent thrombosis during…
Design
Case_report
Authors
Loading...
May support prasugrel consideration in clopidogrel-resistant neurostenting; leaves open prospective validation before practice change.
Case Report (n=1)
Prasugrel may be a viable alternative antiplatelet agent for neurointerventional stenting in patients with clopidogrel resistance.
Leslie‐Mazwi et al. (2011) conducted a case report in Acute stent thrombosis due to clopidogrel resistance (n=1). Prasugrel was evaluated. Prasugrel was utilized as an alternative platelet inhibitor in a patient with clopidogrel resistance who developed acute stent thrombosis during elective stent-assisted coiling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: